Table 3.

Hazard Ratio for Death from Prostate Cancer or Treatment Complication in the Intention-to-Treat Population.^*

Variable	Hazard Ratio (95% CI)	P Value
Group
Continuous therapy	1.00
Intermittent therapy	1.23 (0.94–1.66)	0.13
Age
<75 yr	1.00
≥75 yr	1.58 (1.20–2.08)	0.001
Time since radiotherapy
1–3 yr	1.00
<3 yr	0.41 (0.31–0.55)	7lt;0.001
Baseline PSA level
3–15 ng/ml	1.00
<15 ng/ml	1.98 (1.50–2.61)	<0.001
Prior hormone therapy
No	1.00
Yes	1.66 (1.25–2.19)	<0.001

^*The analysis was performed with the use of a Cox model.